An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial

por Chaker, A. M., Al-Kadah, B., Luther, U., Neumann, U., Wagenmann, M.
Publicado 2016

High probability of comorbidities in bronchial asthma in Germany

por Heck, S., Al-Shobash, S., Rapp, D., Le, D. D., Omlor, A., Bekhit, A., Flaig, M., Al-Kadah, B., Herian, W., Bals, R., Wagenpfeil, S., Dinh, Q. T.
Publicado 2017